30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
In this third installment of our series, we will discuss the new details provided to taxpayers regar...
Read More >
Employers should understand how to handle I-9 inspections by Immigration and Customs Enforcement (IC...
Read More >
We recently wrote about the FAR Council’s release of an interim rule implementing restrictions on p...
Read More >
On August 12, 2019, Governor Cuomo signed the legislation that was passed by the New York State Asse...
Read More >
On April 8, 2020, New Jersey Governor Phil Murphy signed Executive Order No. 122 (“Order 122”) req...
Read More >
Vyne has announced it has been acquired by The Jordan Company from Accel-KKR. Vyne, based in Dunwoo...
Read More >